Targeted Genetics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
08 5월 2008 - 8:30PM
Marketwired
SEATTLE, WA announced today that H. Stewart Parker, President
and Chief Executive Officer, will present a company overview at the
Rodman & Renshaw 5th Annual Global Healthcare Conference on
Monday, May 19 at 9:20 a.m., Monte Carlo, Monaco.
The presentation will be webcast live and available for replay
from the Targeted Genetics website, www.targetedgenetics.com. A
link to connect to the webcast will be under the "Events" section
of the Company's homepage.
About Targeted Genetics
Targeted Genetics Corporation is a biotechnology company
committed to the development of innovative targeted molecular
therapies for the prevention and treatment of acquired and
inherited diseases with significant unmet medical need. Targeted
Genetics' proprietary Adeno-Associated Virus (AAV) technology
platform allows it to deliver genes that encode proteins to
increase gene function or RNAi to decrease or silence gene
function. Targeted Genetics' product development efforts target
inflammatory arthritis, AIDS prophylaxis, congestive heart failure
and Huntington's disease. To learn more about Targeted Genetics,
visit Targeted Genetics' website at www.targetedgenetics.com.
Investor and Media Contact: Stacie D. Byars WeissComm Partners
415.946.1072 Email Contact Carolyn Wang WeissComm Partners
415.946.1065 Email Contact
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
